IDSA GUIDELINES Bundle (free trial)

Drug-Susceptible Tuberculosis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/770889

Contents of this Issue

Navigation

Page 16 of 23

17 Table 6. Other Causes of Abnormal Liver Function Tests That Should Be Excluded • Viral hepatitis (hepatitis A, B, and C in all patients; Epstein-Barr virus, cytomegalovirus, and herpes simplex in immunosuppressed patients) • Biliary tract disease • Alcohol • Other hepatotoxic drugs (eg, acetaminophen, acetaminophen-containing multi-agent preparations, lipid-lowering agents, other drugs) • Select herbal and dietary supplements Table 7. Conditions or Situations in Which Therapeutic Drug Monitoring May Be Helpful • Poor response to tuberculosis treatment despite adherence and fully drug-susceptible Mycobacterium tuberculosis strain • Severe gastrointestinal abnormalities: severe gastroparesis, short bowel syndrome, chronic diarrhea with malabsorption • Drug–drug interactions • Impaired renal clearance: renal insufficiency, peritoneal dialysis, critically ill patients on continuous renal replacement • HIV infection • Diabetes mellitus • Treatment using second-line drugs

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Drug-Susceptible Tuberculosis